ARTICLE: Navigating the new normal for A1c analysis: Interpreting recently released clinical guidelines in the lab
Matthew C. Wagner
Medical Lab Observer, April 22, 2024
Learn how Sebia can help improve your laboratory’s A1C testing in a recent article published by Medical Lab Observer.
This piece offers an in-depth analysis of newly released clinical guidelines for hemoglobin A1C testing and their implications for laboratory practice. It examines key analytical considerations, potential interferences, and standardization challenges associated with A1C measurement in the context of diabetes diagnosis and management. Notably, the guidelines recommend Sebia’s capillary electrophoresis-based A1C testing as a reliable method due to its high specificity and ability to detect common hemoglobin variants. The article also explores how laboratories can interpret and implement these updated recommendations to improve assay accuracy, ensure regulatory compliance, and support better patient outcomes. Designed for clinical laboratorians, the article emphasizes evidence-based strategies to maintain assay integrity in an evolving diagnostic landscape.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.